Induction of polyclonal CD8+ T cell activation and effector function by Pertussis toxin

Cellular Immunology

Volumn 267, Issue 1, 2011, Pages 50-55

  Murphey, Cathi ^a   Chang, Steve ^a   Zhang, Xue ^a   Arulanandam, Bernard ^a   Forsthuber, Thomas G ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Costimulatory molecules; Cytokines; Pertussis toxin; T cell expansion

Indexed keywords

BETA1 INTEGRIN; CD40 LIGAND; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 17; PERTUSSIS TOXIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SUSPENSION; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; IMMUNE SYSTEM; INCUBATION TEMPERATURE; MOUSE; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PERTUSSIS TOXIN;

EID: 78651073831     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.11.003     Document Type: Article

References (41)

1. Mills K.H. Immunity to Bordetella pertussis. Microb. Infect. 2001, 3:655-677.
2. Burnette W.N. Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development. Behring Inst. Mitt. 1997, 434-441.
3. Morse J.H., Kong A.S., Lindenbaum J., Morse S.I. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human lymphocytes. J. Clin. Invest. 1977, 60:683-692.
4. Munoz J.J., Arai H., Bergman R.K., Sadowski P.L. Biological activities of crystalline pertussigen from Bordetella pertussis. Infect. Immun. 1981, 33:820-826.
5. Samore M.H., Siber G.R. Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone. Vaccine 1996, 14:290-297.
6. Tamura S.I., Nakanishi Y., Kojima A., Otokawa M., Uchida N., Sato H., Sato Y. Effects of pertussis toxin (PT) on T-cell populations sensitized for delayed-type hypersensitivity in mice. Cell. Immunol. 1984, 85:351-363.
7. Ryan M., McCarthy L., Rappuoli R., Mahon B.P., Mills K.H. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int. Immunol. 1998, 10:651-662.
8. Shive C.L., Hofstetter H., Arredondo L., Shaw C., Forsthuber T.G. The enhanced antigen-specific production of cytokines induced by pertussis toxin is due to clonal expansion of T cells and not to altered effector functions of long-term memory cells. Eur. J. Immunol. 2000, 30:2422-2431.
9. Jee Y., Matsumoto Y. Two-step activation of T cells, clonal expansion and subsequent Th1 cytokine production is essential for the development of clinical autoimmune encephalomyelitis. Eur. J. Immunol. 2001, 31:1800-1812.
10. Caspi R.R., Silver P.B., Chan C.C., Sun B., Agarwal R.K., Wells J., Oddo S., Fujino Y., Najafian F., Wilder R.L. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J. Immunol. 1996, 157:2668-2675.
11. Yong T., Meininger G.A., Linthicum D.S. Enhancement of histamine-induced vascular leakage by pertussis toxin in SJL/J mice but not BALB/c mice. J. Neuroimmunol. 1993, 45:47-52.
12. Linthicum D.S., Frelinger J.A. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J. Exp. Med. 1982, 156:31-40.
13. Silver P.B., Chan C.C., Wiggert B., Caspi R.R. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment. Invest. Ophthalmol. Vis. Sci. 1999, 40:2898-2905.
14. Hofstetter H.H., Shive C.L., Forsthuber T.G. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J. Immunol. 2002, 169:117-125.
15. Wakatsuki A., Borrow P., Rigley K., Beverley P.C. Cell-surface bound pertussis toxin induces polyclonal T cell responses with high levels of interferon-gamma in the absence of interleukin-12. Eur. J. Immunol. 2003, 33:1859-1868.
16. Denkinger C.M., Denkinger M.D., Forsthuber T.G. Pertussis toxin-induced cytokine differentiation and clonal expansion of T cells is mediated predominantly via costimulation. Cell. Immunol. 2007, 246:46-54.
17. Gray L.S., Huber K.S., Gray M.C., Hewlett E.L., Engelhard V.H. Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein. J. Immunol. 1989, 142:1631-1638.
18. Schneider O.D., Weiss A.A., Miller W.E. Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells. Infect. Immun. 2007, 75:4040-4049.
19. Kundig T.M., Shahinian A., Kawai K., Mittrucker H.W., Sebzda E., Bachmann M.F., Mak T.W., Ohashi P.S. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 1996, 5:41-52.
20. Fang M., Sigal L.J. Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural host. J. Immunol. 2006, 177:8027-8036.
21. McAdam A.J., Farkash E.A., Gewurz B.E., Sharpe A.H. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. J. Virol. 2000, 74:203-208.
22. Fuse S., Zhang W., Usherwood E.J. Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response. J. Immunol. 2008, 180:1148-1157.
23. Borowski A.B., Boesteanu A.C., Mueller Y.M., Carafides C., Topham D.J., Altman J.D., Jennings S.R., Katsikis P.D. Memory CD8+ T cells require CD28 costimulation. J. Immunol. 2007, 179:6494-6503.
24. Thompson C.B., Allison J.P. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997, 7:445-450.
25. van der Merwe P.A., Bodian D.L., Daenke S., Linsley P., Davis S.J. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 1997, 185:393-403.
26. Racke M.K., Hu W., Lovett-Racke A.E. PTX cruiser: driving autoimmunity via TLR4. Trends Immunol. 2005, 26:289-291.
27. Chen X., Howard O.M., Oppenheim J.J. Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells. J. Immunol. 2007, 178:6123-6129.
28. Wong W.S., Simon D.I., Rosoff P.M., Rao N.K., Chapman H.A. Mechanisms of pertussis toxin-induced myelomonocytic cell adhesion: role of Mac-1(CD11b/CD18) and urokinase receptor (CD87). Immunology 1996, 88:90-97.
29. Wong W.S., Luk J.M. Signaling mechanisms of pertussis toxin-induced myelomonocytic cell adhesion: role of tyrosine phosphorylation. Biochem. Biophys. Res. Commun. 1997, 236:479-482.
30. Kerfoot S.M., Long E.M., Hickey M.J., Andonegui G., Lapointe B.M., Zanardo R.C., Bonder C., James W.G., Robbins S.M., Kubes P. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J. Immunol. 2004, 173:7070-7077.
31. Wang Z.Y., Yang D., Chen Q., Leifer C.A., Segal D.M., Su S.B., Caspi R.R., Howard Z.O., Oppenheim J.J. Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways. Exp. Hematol. 2006, 34:1115-1124.
32. Dornan S., Sebestyen Z., Gamble J., Nagy P., Bodnar A., Alldridge L., Doe S., Holmes N., Goff L.K., Beverley P., Szollosi J., Alexander D.R. Differential association of CD45 isoforms with CD4 and CD8 regulates the actions of specific pools of p56lck tyrosine kinase in T cell antigen receptor signal transduction. J. Biol. Chem. 2002, 277:1912-1918.
33. Darabi K., Karulin A.Y., Boehm B.O., Hofstetter H.H., Fabry Z., LaManna J.C., Chavez J.C., Tary-Lehmann M., Lehmann P.V. The third signal in T cell-mediated autoimmune disease?. J. Immunol. 2004, 173:92-99.
34. Walter U., Santamaria P. CD8+ T cells in autoimmunity. Curr. Opin. Immunol. 2005, 17:624-631.
35. Paroli M., Barnaba V. Mechanisms of CD8+ T cell peripheral tolerance to our own antigens. Front. Biosci. 2005, 10:1628-1634.
36. Brisebois M., Zehntner S.P., Estrada J., Owens T., Fournier S. A pathogenic role for CD8+ T cells in a spontaneous model of demyelinating disease. J. Immunol. 2006, 177:2403-2411.
37. Ji Q., Goverman J. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells. Ann. NY Acad. Sci. 2007, 1103:157-166.
38. Pinkse G.G., Tysma O.H., Bergen C.A., Kester M.G., Ossendorp F., van Veelen P.A., Keymeulen B., Pipeleers D., Drijfhout J.W., Roep B.O. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc. Natl. Acad. Sci. USA 2005, 102:18425-18430.
39. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
40. Chen X., Winkler-Pickett R.T., Carbonetti N.H., Ortaldo J.R., Oppenheim J.J., Howard O.M. Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells. Eur. J. Immunol. 2006, 36:671-680.
41. Cassan C., Piaggio E., Zappulla J.P., Mars L.T., Couturier N., Bucciarelli F., Desbois S., Bauer J., Gonzalez-Dunia D., Liblau R.S. Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells. J. Immunol. 2006, 177:1552-1560.